A detailed history of Dagco, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Dagco, Inc. holds 7,700 shares of ABT stock, worth $905,905. This represents 0.36% of its overall portfolio holdings.

Number of Shares
7,700
Previous 7,700 -0.0%
Holding current value
$905,905
Previous $875,000 8.57%
% of portfolio
0.36%
Previous 0.4%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$109.52 - $120.96 $740,902 - $818,294
6,765 Added 723.53%
7,700 $875,000
Q4 2023

Feb 15, 2024

SELL
$90.19 - $110.4 $691,306 - $846,216
-7,665 Reduced 89.13%
935 $102,000
Q3 2022

Nov 01, 2022

SELL
$96.76 - $112.03 $33,866 - $39,210
-350 Reduced 3.91%
8,600 $832,000
Q1 2022

Apr 21, 2022

SELL
$114.02 - $139.04 $10,261 - $12,513
-90 Reduced 1.0%
8,950 $1.07 Million
Q4 2021

Jan 24, 2022

SELL
$115.53 - $141.46 $32,926 - $40,316
-285 Reduced 3.06%
9,040 $1.27 Million
Q3 2021

Nov 01, 2021

SELL
$116.66 - $129.06 $13,999 - $15,487
-120 Reduced 1.27%
9,325 $1.1 Million
Q1 2021

Apr 28, 2021

SELL
$108.84 - $128.23 $46,257 - $54,497
-425 Reduced 4.31%
9,445 $1.13 Million
Q4 2020

Jan 28, 2021

SELL
$105.0 - $114.42 $13,125 - $14,302
-125 Reduced 1.25%
9,870 $1.08 Million
Q2 2020

Jul 27, 2020

SELL
$76.57 - $98.0 $7,656 - $9,800
-100 Reduced 0.99%
9,995 $914,000
Q1 2020

Apr 30, 2020

SELL
$62.82 - $91.86 $28,269 - $41,337
-450 Reduced 4.27%
10,095 $797,000
Q3 2019

Oct 28, 2019

BUY
$81.84 - $88.74 $11,866 - $12,867
145 Added 1.39%
10,545 $882,000
Q2 2019

Aug 08, 2019

SELL
$72.88 - $85.0 $25,508 - $29,750
-350 Reduced 3.26%
10,400 $875,000
Q1 2019

May 13, 2019

SELL
$66.22 - $80.06 $3,311 - $4,003
-50 Reduced 0.46%
10,750 $859,000
Q4 2018

Feb 14, 2019

BUY
$65.56 - $74.27 $708,048 - $802,116
10,800 New
10,800 $781,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Dagco, Inc. Portfolio

Follow Dagco, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dagco, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dagco, Inc. with notifications on news.